Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
about
Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic reviewBasic science and clinical management of painful and non-painful chemotherapy-related neuropathy.Validity and Reliability of a Novel Ocular Pain Assessment Survey (OPAS) in Quantifying and Monitoring Corneal and Ocular Surface Pain.A retrospective study of chronic post-surgical pain following thoracic surgery: prevalence, risk factors, incidence of neuropathic component, and impact on qualify of lifeDepressive symptoms and health-related quality of life in breast cancer survivorsPeripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.Review of neuropathic pain screening and assessment tools.Brief review: chemotherapy-induced painful peripheral neuropathy (CIPPN): current status and future directions.Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors.Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain.Can the LANSS scale be used to classify pain in chronic cancer pain trials?Chronic neuropathic pain negatively associated with employment retention of cancer survivors: evidence from a national French survey.Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross-sectional study.
P2860
Q28270819-CD3A0FC1-FA03-42C9-AD2D-E8A69F545E0DQ33711666-A6391E4D-89C0-4F95-A0CB-5C6CBC8F547CQ33909046-870C92FE-67E6-419D-8923-C5159D167547Q35108565-7EBB76E2-43D6-4E7E-B5DA-26EC2E979825Q35889229-BEC590F9-C813-40A3-B955-A1247280BB8CQ36344699-AEAD0736-D079-43AA-AA6E-1FAFA72A6115Q38133436-94463934-C62E-4DE1-9A71-C91C19C48F96Q38209959-2073AF29-B459-4E6A-B33F-CC75DC9ACFDAQ38850862-EFFCFB2F-5214-4337-B1BC-58AE707210C1Q45169972-D3E832B8-190C-43B4-8580-6C142C2708DEQ47982872-C2A86A75-61D0-4607-8D1A-A0E6F749E0A5Q48248800-3354D7A4-98D0-427E-8FC1-5E4C21AACEE1Q52838772-05A670A7-1003-4026-8F68-0E787ECEE6EF
P2860
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
@ast
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
@en
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
@en-gb
type
label
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
@ast
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
@en
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
@en-gb
prefLabel
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
@ast
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
@en
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
@en-gb
P2093
P2860
P1476
Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.
@en
P2093
Cielito Reyes-Gibby
Mark P Jensen
Phuong Khanh Morrow
Sanjay Shete
P2860
P304
P356
10.1016/J.JPAINSYMMAN.2009.09.020
P577
2010-05-01T00:00:00Z